Clinical trial
Hydroxychloroquine Treatment for Severe COVID-19 Respiratory Disease: Randomised Clinical Trial (HYDRA Trial)
NCT04315896 is registered in ClinicalTrials.gov with National Institute of Respiratory Diseases, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxychloroquine Treatment for Severe COVID-19 Respiratory Disease: Randomised Clinical Trial (HYDRA Trial)
- Lead sponsor
- National Institute of Respiratory Diseases, Mexico
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 14, 2020
- Completion date
- August 15, 2020
- Enrollment
- 320 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.